Innovative Solutions in Immunology, Radioligands, and Immunotherapies
The Emerging Therapeutics Stream at PEGS 2025 offers an in-depth exploration of cutting-edge advancements across three pivotal tracks. The Biologics for Immunology Indications track focuses on preclinical research and innovative strategies for complex immunological conditions, from autoimmunity to rare diseases, emphasizing novel therapeutic approaches and early-stage research. The Targeted Radioligand Therapies track investigates the forefront of radiopharmaceuticals, combining targeted molecules with radioisotopes for precise cancer treatment, addressing advancements, challenges, and clinical considerations. Lastly, the Next Generation Immunotherapies track covers the latest in target discovery and validation, including emerging technologies and novel targets for cancer and other diseases. Together, these tracks provide a comprehensive view of therapeutic innovations driving the future of biologic and targeted treatments.
Conferences Include:
May 12-13
Biologics for Immunology Indications
May 13-14
Radiopharmaceutical Therapies
May 15-16
Next-Generation Immunotherapies